IGC icon

IGC Pharma
IGC

Overview Fund Activity

25 hedge funds and large institutions have $692K invested in IGC Pharma in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
25
Holders Change
-2
Holders Change %
-7.41%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
4
Closed
7
Calls
$37K
Puts
$6K
Net Calls
+$31K
Net Calls Change
-$6K

Top Buyers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$21.5K
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$1.38K
3
UBS Group
3
UBS Group
Switzerland
$1.33K
4
TRCT
4
Tower Research Capital (TRC)
New York
$6.53K
5
Morgan Stanley
5
Morgan Stanley
New York
$482

Top Sellers

1
Commonwealth Equity Services
1
Commonwealth Equity Services
Massachusetts
$0
2
Renaissance Technologies
2
Renaissance Technologies
New York
$0
3
TSS
3
Two Sigma Securities
New York
$0
4
Jane Street
4
Jane Street
New York
$0
5
HF
5
HRT Financial
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Commonwealth Equity Services
26
Commonwealth Equity Services
Massachusetts
– -$59K -165,490 Closed
Renaissance Technologies
27
Renaissance Technologies
New York
– -$31K -86,902 Closed
TSS
28
Two Sigma Securities
New York
– -$17.2K -47,750 Closed
Jane Street
29
Jane Street
New York
– -$16.7K -46,540 Closed
HF
30
HRT Financial
New York
– -$6K -18,148 Closed
Millennium Management
31
Millennium Management
New York
– -$5.13K -14,276 Closed
Bank of America
32
Bank of America
North Carolina
– -$90 -250 Closed
1
2